Skip to main content
. 2022 May 25;12:8886. doi: 10.1038/s41598-022-13046-y

Table 4.

Univariate and multivariate analyses of risk factors with and OS in the validation cohort.

Variables HR (95% CI) P value
Univariate analyses
Age (years) (> 60 vs. ≤ 60) 0.923 (0.507, 1.680) 0.794
Gender (male vs. female) 0.797 (0.436, 1.458) 0.461
BMI 1.023 (0.992, 1.055) 0.145
Child–Pugh classification (B and C vs. A) 0.967 (0.286, 3.274) 0.957
Alcohol consumption (yes vs. no) 0.558 (0.245, 1.267) 0.163
Hepatitis B (yes vs. no) 0.591 (0.270, 1.292) 0.188
Hepatitis C (yes vs. no) 1.051 (0.498, 2.221) 0.896
Histologic grade (G3-4 vs. G1-2) 1.778 (0.952, 3.323) 0.071
Microvascular invasion (yes vs. no) 1.156 (0.555, 2.407) 0.698
AJCC tumor stage (III and IV vs. I and II) 1.329 (0.691, 2.554) 0.393
Risk score 1.564 (1.200, 2.037) 0.001
Multivariate analyses
AJCC tumor stage (III and IV vs. I and II) 0.569 (0.628, 2.331) 0.569
Risk score 1.756 (1.208, 2.554) 0.003

HR, hazard ratio; CI, confidence interval; OS, overall survival; BMI, body mass index; AJCC, American Joint Committee on Cancer.